4th European Clinical Quality Risk Management Forum

Memo

The European Clinical Quality Risk Management Forum in London on 24–25 February, provides a forum for senior-level clinical quality, compliance and operations executives from leading pharma, biotech and medical device companies, to candidly discuss strategies for ensuring trial integrity through proactive clinical risk management. Learn from this experienced group and take-away proven, results-driven, risk-based strategies for optimizing your company’s clinical quality to achieve a continual state of inspection readiness. Testimonials:"The conference created a space to absorb current thoughts on executing quality strategies, along with providing fantastic opportunities to network with a bunch of friendly and likeminded individuals." - Clinical QA Program Manager, AbbVie“Excellent sessions with interesting and helpful insights into the thinking of inspectors.” – Director, Clinical Operations, Shionogi"Really good conference. I enjoy the ExL conferences as they are a great mix of large and small companies and experienced people." - Associate Director, Quality Assurance GCP, Aimmune Therapeutics“Excellent range of hot topics and engaging speakers. Very interactive and enjoyable.” – Director, Quality and Risk Management, AstraZeneca"This congress was a great opportunity to share knowledge and experiences. It was a real pleasure and honor for me to be part of it. Many thanks to the team and all the speakers. I hope there will be a follow-up congress coming next year." - Global Clinical Quality Assurance, Compliance and Data Integrity Officer, Novartis URLs: Tickets https://go.evvnt.com/534256-1?pid=5569Brochure https://go.evvnt.com/534256-3?pid=5569 Prices:Early Bird Rate: GBP 1495.00,Standard: GBP 1595.00,Onsite: GBP 1795.00. Speakers: Chairperson - DAVID FRYREAR, SENIOR VICE PRESIDENT, HEAD OF CLINICAL & RESEARCH QUALITY ASSURANCE, ASTELLAS. Time: 8:00 am to 5:00 pm. Venue details: London Marriott Hotel Regents Park, 128 King Henry's Road, London, England, NW3 3ST, United Kingdom.